Oxygen nanobubbles

Oxygen nanobubbles has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 10, 2026: “Nanobubble-Mediated Oxygen Delivery Mitigates Hypoxia-Induced ROS and HIF-1α Expression in UC-MSCs”.

Intervention

1 paper studies it3 findingsUpdated

See all 1 papers on oxygen nanobubbles

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Agencia Nacional de Investigación y Desarrollo and 1 more
  • Cells1

What did studies of oxygen nanobubbles find?

3

Studies of oxygen nanobubbles measured 3 outcomes: HIF1A, oxidative stress and ROS signaling and cell viability.

HIF1A

downin human cells1

1 study
  1. Oxygen nanobubbles decrease HIF1A in human cells (~8-9 fold).

    Cellsunder hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS) relative to untreated hypoxic controls

More on HIF1A

Oxidative stress and ROS signaling

downin human cells1−20%

1 study
  1. Oxygen nanobubbles decrease oxidative stress and ROS signaling in human cells under hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS) (~20%).

    Cellsunder hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS)

More on Oxidative stress and ROS signaling

Cell viability

upin human cells1

1 study
  1. Oxygen nanobubbles improve cell viability in human cells under hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS).

    Cellsunder hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS)

More on Cell viability

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months